KLRK1 and central nervous system cancer: To confirm the 3D microscopy analysis, we intravenously injected CD45.1+ immune cells, transfected with NKG2D CAR mRNA, into CD45.2+ glioma-bearing mice and quantified the number of tumor-infiltrating cells using ex vivo flow cytometry (Figure S3A).